Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Bio Sciences Ltd has informed BSE that its audited financial results for the quarter and full year ended March 31, 2025 were published in newspapers on June 3, 2025. The results appeared in The Business Dairy (English) and The Praja Palana (Telugu), fulfilling SEBI's Regulation 47 disclosure requirement under the Listing Obligations and Disclosure Requirements Regulations, 2015. The filing was signed by Managing Director Venkata Rama Mohan Raju Jampana. A copy of the published results is also available on the company's website. Based on the published figures, the company reported revenue from operations of around Rs. 102 lakhs for the quarter, with total expenses of about Rs. 452 lakhs, indicating a loss before tax of approximately Rs. 72 lakhs for the period.
This is a routine regulatory compliance filing and does not represent new information for investors, since the audited results were already filed with BSE earlier. Shareholders should focus on the actual financials, which suggest the company continues to operate at a loss with expenses significantly exceeding revenue, indicating ongoing financial stress.